Labaru

A cikin farkon rabin 2022, fitarwa na kayayyakin kiwon lafiya kamar maganin Koriya, kayan aikin likita da kayan kwalliya sun kai rikodin sosai. COVID-19 reagents da allurar rigakafi sun inganta fitarwa.
A cewar Cibiyar Kasashen Koriya ta Koriya (Khidi), fitowar masana'antar ta samo asali dala biliyan 13.35 a farkon rabin wannan shekara. Wannan adadi ya tashi kashi 8.5% daga $ 12.3 biliyan a shekarar da ta gabata kwata-kwata kuma shine mafi girman shekaru a sakamakon har abada. An yi rikodin akan $ 13,15 biliyan a farkon rabin na biyu na 2021.
Ta masana'antu, fitar da kayayyakin magunguna na dala biliyan 4.35, sama da 45.0% daga dala biliyan 3.0 a cikin wannan lokacin a cikin shekaru 2021. Fitar da Na'urorin kiwon lafiya ya zama kashi 5.2% a shekara. Saboda cin hanci a China, fitarwa na kwaskwarimar kwaskwarima sun fadi ta 11.9% zuwa dala biliyan 4.06.
Girma a cikin magungunan magunguna da aka kora ta hanyar biopharmaneuticals da rigakafin. Fitar da biopharmaceuticals ya kai biliyan 1.68, yayin fitar da allurar rigakafin cutar sun kai $ 780 miliyan. Dukansu asusun na 56.4% na dukkanin fitarwa na magunguna. Musamman, allurar rigakafin allurar rigakafin sun karu da 490.8% na shekara 49.0 saboda fadada fitar da maganin rigakafin magungunan COVID-19 sun samar karkashin masana'antar kwangilar kwangila.
A cikin filin na'urorin likitanci, asusun reagents asusun don mafi girman rabo, kai miliyan 2.40) ya ci gaba da girma, galibi a cikin Amurka da China.